SER
Price:
$5.36
Market Cap:
$53.43M
Serina Therapeutics, Inc., a biotechnology company, develops drugs to treat neurological diseases and pain. Its lead product candidate is SER 252, a POZ conjugate for the treatment of Parkinson's disease. The company also develops SER 227 for long-acting pain relief; SER 214 to treat Parkinson's disease; and SER 228 for the treatment of epilepsy. In addition, it develops POZ technology in lipid nanoparticle delivered ribonucleic acid vaccines for infectious diseases. Serina Therapeutics, Inc. was founded in 2006 and is based in Huntsville, Alabama.
Industry
Biotechnology
IPO Date
2000-01-21
Stock Exchange
NYSE
Ticker
SER
According to Serina Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is 13.51%. This represents a change of -107.18% compared to the average of -188.11% of the last 4 quarters.
The mean historical ROE of Serina Therapeutics, Inc. over the last ten years is -230.05%. The current 13.51% ROE has changed -105.87% with respect to the historical average. Over the past ten years (40 quarters), SER's ROE was at its highest in in the March 2020 quarter at 431.26%. The ROE was at its lowest in in the December 2024 quarter at -427.46%.
Average
-230.05%
Median
7.10%
Minimum
-1738.07%
Maximum
212.37%
Discovering the peaks and valleys of Serina Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.26%
Maximum Annual ROE = 212.37%
Minimum Annual Increase = -1904.04%
Minimum Annual ROE = -1738.07%
Year | ROE | Change |
---|---|---|
2024 | -1738.07% | -1904.04% |
2023 | 96.34% | 1.26% |
2022 | 7.10% | -71.27% |
2021 | 24.71% | -88.36% |
2020 | 212.37% | -138.76% |
2019 | -547.97% | 443.95% |
2018 | -100.74% | 11.46% |
2017 | -90.38% | -236.63% |
The current ROE of Serina Therapeutics, Inc. (SER) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-544.87%
5-year avg
-279.51%
10-year avg
-230.05%
Serina Therapeutics, Inc.’s ROE is
Company | ROE | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Serina Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Serina Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Serina Therapeutics, Inc.'s ROE?
How is the ROE calculated for Serina Therapeutics, Inc. (SER)?
What is the highest ROE for Serina Therapeutics, Inc. (SER)?
What is the 3-year average ROE for Serina Therapeutics, Inc. (SER)?
What is the 5-year average ROE for Serina Therapeutics, Inc. (SER)?
How does the current ROE for Serina Therapeutics, Inc. (SER) compare to its historical average?